4//SEC Filing
Preston Heather 4
Accession 0001209191-21-038583
CIK 0001805890other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:18 PM ET
Size
9.2 KB
Accession
0001209191-21-038583
Insider Transaction Report
Form 4
Preston Heather
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-04+17,000→ 17,000 totalExercise: $8.15Exp: 2031-06-03→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]This option fully vests on the earlier of (i) June 4, 2022 or (ii) the 2022 Annual Meeting of Shareholders of Fusion Pharmaceuticals Inc.
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeother
Related Parties
1- filerCIK 0001606826
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:18 PM ET
- Size
- 9.2 KB